Medicure Inc. To Present At Needham & Company Biotechnology And Medical Technology Conference

WINNIPEG, MANITOBA -- (MARKET WIRE) -- 06/08/2006 -- Medicure Inc. (TSX: MPH)(AMEX: MCU), a cardiovascular drug discovery and development company, today announced its President and CEO, Albert D. Friesen, PhD, will deliver a corporate presentation at the 5th Annual Needham & Company Biotechnology and Medical Technology Conference at the New York Palace Hotel at 11:30 AM Eastern on Thursday June 15, 2006 in New York City. The presentation will be webcast live and can be accessed on the Medicure website at www.medicure.com.
MORE ON THIS TOPIC